Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Estrogen-producing neurons influence aggression in both sexes

  • Secrets of a clump-dissolving protein uncovered

  • Family voices, stories speed coma recovery

  • Prescription painkillers, widely used by childbearing age women, double birth defects risk

  • Low-income boys fare worse in wealth's shadow

  • Tablet computers good medium for educational materials

  • Anti-inflammatory protein may trigger plaque in Alzheimer's disease

  • Pro-marijuana 'tweets' are sky-high on Twitter

  • Genome-wide search reveals new genes involved in long-term memory

  • Why should adolescents exhibiting symptoms of mental disorders be asked about hallucinations?

  •